Ikena Oncology Inc
NASDAQ:IKNA
Cash Flow Statement
Cash Flow Statement
Ikena Oncology Inc
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(23)
|
(44)
|
(54)
|
(55)
|
(63)
|
(34)
|
(41)
|
(49)
|
(52)
|
(69)
|
(66)
|
(63)
|
(63)
|
(68)
|
(70)
|
(67)
|
(60)
|
(49)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Stock-Based Compensation |
0
|
2
|
3
|
4
|
5
|
5
|
6
|
7
|
7
|
8
|
8
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
2
|
14
|
15
|
15
|
17
|
6
|
7
|
8
|
9
|
9
|
9
|
8
|
7
|
9
|
10
|
10
|
9
|
7
|
|
| Change in Working Capital |
(12)
|
(8)
|
(12)
|
(10)
|
(13)
|
(33)
|
(34)
|
(31)
|
(27)
|
(15)
|
(17)
|
(19)
|
(21)
|
(22)
|
(19)
|
(17)
|
(12)
|
(4)
|
|
| Cash from Operating Activities |
(33)
N/A
|
(38)
-14%
|
(51)
-35%
|
(49)
+4%
|
(59)
-21%
|
(60)
-1%
|
(67)
-11%
|
(71)
-6%
|
(70)
+1%
|
(74)
-6%
|
(74)
N/A
|
(73)
+2%
|
(76)
-4%
|
(80)
-6%
|
(78)
+2%
|
(73)
+7%
|
(62)
+15%
|
(46)
+25%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other Items |
0
|
4
|
0
|
0
|
0
|
0
|
(166)
|
(146)
|
(109)
|
(98)
|
58
|
60
|
55
|
65
|
26
|
8
|
(15)
|
(35)
|
|
| Cash from Investing Activities |
(0)
N/A
|
3
N/A
|
2
-29%
|
2
-3%
|
2
-9%
|
(2)
N/A
|
(167)
-9 387%
|
(146)
+12%
|
(110)
+25%
|
(99)
+10%
|
56
N/A
|
58
+4%
|
54
-7%
|
64
+18%
|
26
-59%
|
7
-72%
|
(15)
N/A
|
(35)
-133%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
0
|
116
|
249
|
248
|
248
|
132
|
(0)
|
1
|
1
|
1
|
1
|
37
|
37
|
37
|
0
|
(0)
|
0
|
0
|
|
| Other |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
39
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
116
+580 800%
|
249
+114%
|
248
0%
|
248
+0%
|
132
-47%
|
(0)
N/A
|
1
N/A
|
1
-4%
|
1
-17%
|
1
-45%
|
37
+6 072%
|
76
+105%
|
76
+0%
|
0
N/A
|
39
N/A
|
0
-100%
|
0
N/A
|
|
| Change in Cash | |||||||||||||||||||
| Net Change in Cash |
(34)
N/A
|
81
N/A
|
200
+146%
|
200
+0%
|
190
-5%
|
70
-63%
|
(234)
N/A
|
(216)
+8%
|
(179)
+17%
|
(172)
+4%
|
(18)
+90%
|
22
N/A
|
55
+144%
|
60
+11%
|
24
-60%
|
(26)
N/A
|
(76)
-192%
|
(81)
-6%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(34)
N/A
|
(39)
-15%
|
(53)
-36%
|
(51)
+3%
|
(61)
-21%
|
(62)
-1%
|
(68)
-9%
|
(71)
-5%
|
(72)
0%
|
(76)
-6%
|
(76)
0%
|
(74)
+2%
|
(76)
-2%
|
(80)
-6%
|
(79)
+2%
|
(73)
+7%
|
(62)
+15%
|
(46)
+26%
|
|